×
About 1,328 results

ALLMedicine™ Oropharyngeal Cancer Center

Research & Reviews  645 results

Patient-reported quality of life and symptom burden measures in human papillomavirus as...
https://doi.org/10.1016/j.oraloncology.2021.105309
Oral Oncology; McDowell L, Gough K et. al.

May 2nd, 2021 - The emergence of human papillomavirus-associated oropharyngeal cancer (HPVOPC) has resulted in an explosion of clinical research offering reduced toxicity and improved health-related quality of life (HRQL) through treatment de-escalation. At the h...

Diagnostic approaches to carcinoma of unknown primary of the head and neck.
https://doi.org/10.1111/ecc.13459
European Journal of Cancer Care; Ye W, Arnaud EH et. al.

May 1st, 2021 - Squamous cell carcinoma in cervical lymph nodes arising from an undetected primary tumour, termed carcinoma of unknown primary (SCCUP), is a well-recognized clinical presentation within head and neck oncology. SCCUP is a common presentation for pa...

HPV DNA genotyping, HPV E6*I mRNA detection, and p16INK4a/Ki-67 staining in Belgian hea...
https://doi.org/10.1016/j.canep.2021.101925
Cancer Epidemiology; Simoens C, Gorbaslieva I et. al.

Apr 11th, 2021 - The main risk factors for head and neck cancer (HNC) are tobacco and alcohol use. However, an important fraction of oropharyngeal cancer (OPC) is caused by human papillomaviruses (HPV), a subgroup with increasing incidence in several western count...

Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xeros...
https://doi.org/10.1016/j.radonc.2021.03.036
Radiotherapy and Oncology : Journal of the European Socie... Cao J, Zhang X et. al.

Apr 11th, 2021 - To determine rates of xerostomia after intensity-modulated radiotherapy (IMRT) or intensity-modulated proton therapy (IMPT) for oropharyngeal cancer (OPC) and identify dosimetric factors associated with xerostomia risk. Patients with OPC who recei...

The impact of induction and/or concurrent chemoradiotherapy on acute and late patient-r...
https://doi.org/10.1002/cncr.33501
Cancer van Dijk LV, Mohamed ASR et. al.

Mar 31st, 2021 - The goal of this study was to comprehensively investigate the association of chemotherapy with trajectories of acute symptom development and late symptom recovery in patients with oropharyngeal cancer (OPC) by comparing symptom burden between indu...

see more →

Clinicaltrials.gov  667 results

Patient-reported quality of life and symptom burden measures in human papillomavirus as...
https://doi.org/10.1016/j.oraloncology.2021.105309
Oral Oncology; McDowell L, Gough K et. al.

May 2nd, 2021 - The emergence of human papillomavirus-associated oropharyngeal cancer (HPVOPC) has resulted in an explosion of clinical research offering reduced toxicity and improved health-related quality of life (HRQL) through treatment de-escalation. At the h...

Diagnostic approaches to carcinoma of unknown primary of the head and neck.
https://doi.org/10.1111/ecc.13459
European Journal of Cancer Care; Ye W, Arnaud EH et. al.

May 1st, 2021 - Squamous cell carcinoma in cervical lymph nodes arising from an undetected primary tumour, termed carcinoma of unknown primary (SCCUP), is a well-recognized clinical presentation within head and neck oncology. SCCUP is a common presentation for pa...

HPV DNA genotyping, HPV E6*I mRNA detection, and p16INK4a/Ki-67 staining in Belgian hea...
https://doi.org/10.1016/j.canep.2021.101925
Cancer Epidemiology; Simoens C, Gorbaslieva I et. al.

Apr 11th, 2021 - The main risk factors for head and neck cancer (HNC) are tobacco and alcohol use. However, an important fraction of oropharyngeal cancer (OPC) is caused by human papillomaviruses (HPV), a subgroup with increasing incidence in several western count...

Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xeros...
https://doi.org/10.1016/j.radonc.2021.03.036
Radiotherapy and Oncology : Journal of the European Socie... Cao J, Zhang X et. al.

Apr 11th, 2021 - To determine rates of xerostomia after intensity-modulated radiotherapy (IMRT) or intensity-modulated proton therapy (IMPT) for oropharyngeal cancer (OPC) and identify dosimetric factors associated with xerostomia risk. Patients with OPC who recei...

The impact of induction and/or concurrent chemoradiotherapy on acute and late patient-r...
https://doi.org/10.1002/cncr.33501
Cancer van Dijk LV, Mohamed ASR et. al.

Mar 31st, 2021 - The goal of this study was to comprehensively investigate the association of chemotherapy with trajectories of acute symptom development and late symptom recovery in patients with oropharyngeal cancer (OPC) by comparing symptom burden between indu...

see more →

News  15 results

ASCO: Deintensified treatment in p16+ oropharyngeal cancer needs evaluation
https://www.mdedge.com/hematology-oncology/article/200108/head-neck-cancers/asco-deintensified-treatment-p16-oropharyngeal?channel=39313
Caleb Rans

May 2nd, 2019 - Treatment deintensification for patients with p16+ oropharyngeal cancer (OPC) should occur only in the context of a clinical trial, according to a provisional clinical opinion released by the American Society of Clinical Oncology (ASCO). “The hypo.

HPV16 Vaccine Yields Added Benefit in Recurrent Throat Cancer
https://www.medpagetoday.com/hematologyoncology/othercancers/75474

Oct 3rd, 2018 - NEW YORK CITY -- Adding a tumor-specific vaccine to PD-1 checkpoint inhibition was safe and effective in HPV16-positive patients with recurrent or metastatic oropharyngeal cancer, a small phase II trial found. Among 24 patients treated with nivolu...

Risk for HPV-Related Throat Cancer Is 'Reassuringly' Low
https://www.staging.medscape.com/viewarticle/887728

Oct 26th, 2017 - The risk of developing oropharyngeal cancer (OPC) related to oral human papillomavirus (HPV) infection is very low in the general population and even in people with specific behavioral risk factors, a new study suggests. "Oropharyngeal cancer has ...

Risk for HPV-Related Throat Cancer Is 'Reassuringly' Low
https://www.medscape.com/viewarticle/887728

Oct 26th, 2017 - The risk of developing oropharyngeal cancer (OPC) related to oral human papillomavirus (HPV) infection is very low in the general population and even in people with specific behavioral risk factors, a new study suggests. "Oropharyngeal cancer has ...

Oral Sex, Smoking Increase Men's HPV Risk
https://www.medpagetoday.com/infectiousdisease/stds/68723

Oct 23rd, 2017 - Action Points Men who smoked and had five or more lifetime oral sex partners had the highest prevalence of oral oncogenic human papilloma virus (HPV) infection (14.9%). The study suggests that even though the prevalence of infection is higher in m...

see more →

Patient Education  1 results see all →